首页 > 最新文献

International Journal of Surgery Protocols最新文献

英文 中文
Intramuscular Electrical Stimulation Combined with Therapeutic Exercises in Patients with Shoulder Adhesive Capsulitis: A Randomised Controlled Trial. 肌内电刺激联合治疗性运动治疗肩粘连性囊炎:一项随机对照试验
IF 0.9 Q3 SURGERY Pub Date : 2021-05-18 DOI: 10.29337/ijsp.25
Sukumar Shanmugam, Lawrence Mathias, Nagarajan Manickaraj, K U Dhanesh Kumar, Praveen Kumar Kandakurti, Sathees Kumar Dorairaj, Ramprasad Muthukrishnan

Background: Myofascial trigger points (MTrPs) precipitate the shoulder pain severity and disability in patients with shoulder adhesive capsulitis (SAC). This study aims to compare the effectiveness of intramuscular electrical stimulation (IMES) combined with therapeutic exercises versus dry needling (DN) combined with therapeutic exercises in improving the clinical outcomes in patients with SAC.

Methods and materials: In this randomized controlled trial, IMES (n = 45) and DN (43) groups had received respectively IMES, and DN twice weekly for three consecutive weeks. Both groups received therapeutic exercises 1520 minutes, five days in a week during the second and third week. Pain, disability, kinesiophobia, number of active and latent MTrPs, shoulder abduction and external rotation range of motion were assessed at baseline, week-1, week-2, week-3 and follow-up at 3 months. A repeated measures ANOVA performed to find out the significant differences in the clinical outcomes between the groups.

Results: The results of repeated measures of ANOVA shows that the post intervention timelines assessment scores of VAS, DASH, shoulder abduction and external rotation ROM, number of active and latent MTrPs and kinesiophobia were significantly (p. < 0.05) improved in both groups. However, IMES group had achieved a greater improvement over DN group (p. < 0.05) on the shoulder pain severity and disability, shoulder range of motion, number of active and latent MTrPs and kinesiophobia. Despite the significant statistical differences between the groups, IMES group did not achieve the minimal clinically important differences of 1.5cm and 11-points respectively for the VAS and DASH scores. No serious adverse effects occurred during the three weeks of treatment.

Conclusion: IMES combined with therapeutic exercises is an effective treatment to reduce the shoulder pain severity and upper limb disability by deactivating the active and latent MTrPs and improving the shoulder abduction and external rotation range of motion in patients with SAC.

背景:肌筋膜触发点(MTrPs)与肩粘连性囊炎(SAC)患者的肩痛严重程度和残疾有关。本研究旨在比较肌内电刺激(IMES)联合治疗性运动与干针(DN)联合治疗性运动在改善SAC患者临床预后方面的有效性。方法与材料:随机对照试验,IMES组(n = 45)和DN组(43)分别接受IMES和DN治疗,每周2次,连续3周。两组在第二和第三周均进行治疗性运动,每次1520分钟,每周5天。在基线、第1周、第2周、第3周和3个月随访时评估疼痛、残疾、运动恐惧症、活动和潜在mtrp数量、肩关节外展和外旋活动范围。进行重复测量方差分析以找出组间临床结果的显著差异。结果:方差分析的重复测量结果显示,两组患者干预后时间线VAS、DASH、肩外展和外旋ROM评分、活跃和潜伏MTrPs数、运动恐惧症得分均有显著改善(p < 0.05)。然而,IMES组在肩部疼痛严重程度和失能程度、肩部活动范围、活动和潜伏MTrPs数量以及运动恐惧方面比DN组有更大的改善(p < 0.05)。尽管组间差异有统计学意义,但IMES组VAS评分和DASH评分均未达到1.5cm和11分的最小临床重要差异。三周治疗期间未发生严重不良反应。结论:IMES联合治疗性运动是一种有效的治疗方法,通过使活动和潜伏的MTrPs失活,改善SAC患者的肩外展和外旋活动范围,减轻肩部疼痛严重程度和上肢残疾。
{"title":"Intramuscular Electrical Stimulation Combined with Therapeutic Exercises in Patients with Shoulder Adhesive Capsulitis: A Randomised Controlled Trial.","authors":"Sukumar Shanmugam,&nbsp;Lawrence Mathias,&nbsp;Nagarajan Manickaraj,&nbsp;K U Dhanesh Kumar,&nbsp;Praveen Kumar Kandakurti,&nbsp;Sathees Kumar Dorairaj,&nbsp;Ramprasad Muthukrishnan","doi":"10.29337/ijsp.25","DOIUrl":"https://doi.org/10.29337/ijsp.25","url":null,"abstract":"<p><strong>Background: </strong>Myofascial trigger points (MTrPs) precipitate the shoulder pain severity and disability in patients with shoulder adhesive capsulitis (SAC). This study aims to compare the effectiveness of intramuscular electrical stimulation (IMES) combined with therapeutic exercises versus dry needling (DN) combined with therapeutic exercises in improving the clinical outcomes in patients with SAC.</p><p><strong>Methods and materials: </strong>In this randomized controlled trial, IMES (n = 45) and DN (43) groups had received respectively IMES, and DN twice weekly for three consecutive weeks. Both groups received therapeutic exercises 1520 minutes, five days in a week during the second and third week. Pain, disability, kinesiophobia, number of active and latent MTrPs, shoulder abduction and external rotation range of motion were assessed at baseline, week-1, week-2, week-3 and follow-up at 3 months. A repeated measures ANOVA performed to find out the significant differences in the clinical outcomes between the groups.</p><p><strong>Results: </strong>The results of repeated measures of ANOVA shows that the post intervention timelines assessment scores of VAS, DASH, shoulder abduction and external rotation ROM, number of active and latent MTrPs and kinesiophobia were significantly (p. < 0.05) improved in both groups. However, IMES group had achieved a greater improvement over DN group (p. < 0.05) on the shoulder pain severity and disability, shoulder range of motion, number of active and latent MTrPs and kinesiophobia. Despite the significant statistical differences between the groups, IMES group did not achieve the minimal clinically important differences of 1.5cm and 11-points respectively for the VAS and DASH scores. No serious adverse effects occurred during the three weeks of treatment.</p><p><strong>Conclusion: </strong>IMES combined with therapeutic exercises is an effective treatment to reduce the shoulder pain severity and upper limb disability by deactivating the active and latent MTrPs and improving the shoulder abduction and external rotation range of motion in patients with SAC.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"71-83"},"PeriodicalIF":0.9,"publicationDate":"2021-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139297/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38966372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A Study Protocol to Explore and Improve Access to Medical Services and Information for Recently Diagnosed Elderly Patients with Cancer in Rural Settings. 探索和改善农村地区新近诊断的老年癌症患者获得医疗服务和信息的研究方案
IF 0.9 Q3 SURGERY Pub Date : 2021-04-30 DOI: 10.29337/ijsp.144
Gianina-Ioana Postavaru, Bethan Myers, Tanweer Ahmed, Douglas Lewins, Rosemary Brown, Helen Swaby

Introduction: This two-phase study seeks to contribute to research in the field of rural cancer health; specifically, the aim is to gain insight into the experiences of seeking, accessing and using information and health services throughout the cancer journey (diagnosis, treatment and follow-up care) for recently diagnosed (≤6 months) older patients (≥65 years) in rural areas.

Methods and analysis: Data will be collected through in-depth semi-structured interviews. In phase 1 (before 23rd March 2020) interviews were conducted with healthcare professionals (HCP) to explore their experiences of delivering care to their elderly patients. In the second phase (starting January 2021) we will conduct interviews with cancer patients to understand the impact of COVID-19 and shielding on their experiences of being diagnosed, attending appointments and accessing and receiving support from community organisations and informal support from family and friends. Data gathered will be analysed using the Framework Method.

Ethics: The study has been approved by the Health Research Authority and the United Lincolnshire Hospitals NHS Trust. Initial favourable ethical opinion was granted on 1st October 2019. Second favourable ethical opinion for amendments to reflect the impact of COVID-19 was received on 10th August 2020. The study protocol has been registered on Research Registry.

前言:这项两阶段的研究旨在促进农村癌症健康领域的研究;具体而言,目的是深入了解农村地区最近确诊(≤6个月)的老年患者(≥65岁)在整个癌症过程(诊断、治疗和后续护理)中寻求、获取和使用信息和卫生服务的经验。方法与分析:通过深度半结构化访谈收集数据。在第一阶段(2020年3月23日之前),对医疗保健专业人员(HCP)进行了访谈,以了解他们为老年患者提供护理的经验。在第二阶段(从2021年1月开始),我们将对癌症患者进行访谈,以了解COVID-19和屏蔽对他们被诊断、就诊、获得和接受社区组织支持以及家人和朋友非正式支持的经历的影响。收集的数据将使用框架方法进行分析。伦理:这项研究已经得到了健康研究机构和林肯郡联合医院NHS信托的批准。最初的有利伦理意见于2019年10月1日获得批准。2020年8月10日收到了第二份赞成修订以反映COVID-19影响的道德意见。研究方案已在研究注册中心注册。
{"title":"A Study Protocol to Explore and Improve Access to Medical Services and Information for Recently Diagnosed Elderly Patients with Cancer in Rural Settings.","authors":"Gianina-Ioana Postavaru,&nbsp;Bethan Myers,&nbsp;Tanweer Ahmed,&nbsp;Douglas Lewins,&nbsp;Rosemary Brown,&nbsp;Helen Swaby","doi":"10.29337/ijsp.144","DOIUrl":"https://doi.org/10.29337/ijsp.144","url":null,"abstract":"<p><strong>Introduction: </strong>This two-phase study seeks to contribute to research in the field of rural cancer health; specifically, the aim is to gain insight into the experiences of seeking, accessing and using information and health services throughout the cancer journey (diagnosis, treatment and follow-up care) for recently diagnosed (≤6 months) older patients (≥65 years) in rural areas.</p><p><strong>Methods and analysis: </strong>Data will be collected through in-depth semi-structured interviews. In phase 1 (before 23<sup>rd</sup> March 2020) interviews were conducted with healthcare professionals (HCP) to explore their experiences of delivering care to their elderly patients. In the second phase (starting January 2021) we will conduct interviews with cancer patients to understand the impact of COVID-19 and shielding on their experiences of being diagnosed, attending appointments and accessing and receiving support from community organisations and informal support from family and friends. Data gathered will be analysed using the Framework Method.</p><p><strong>Ethics: </strong>The study has been approved by the Health Research Authority and the United Lincolnshire Hospitals NHS Trust. Initial favourable ethical opinion was granted on 1<sup>st</sup> October 2019. Second favourable ethical opinion for amendments to reflect the impact of COVID-19 was received on 10<sup>th</sup> August 2020. The study protocol has been registered on Research Registry.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"66-70"},"PeriodicalIF":0.9,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profile of Patients with Gallstone Disease in a Sub-Saharan African General Surgery Department: A Retrospective Cohort Study Protocol. 撒哈拉以南非洲地区普通外科胆结石患者概况:一项回顾性队列研究方案
IF 0.9 Q3 SURGERY Pub Date : 2021-04-27 DOI: 10.29337/ijsp.143
A Ndong, N F Gaye, J N Tendeng, M L Diao, A C Diallo, F G Niang, S Diop, D A Dia, M Diedhiou, M Dieng, M L Fall, P M Ma Nyemb, I Konaté

Introduction: Gallstone disease is a disorder characterised by the formation of stones in the biliary tract. It is the most common biliary condition accounting for more than 98% of all gallbladder and biliary tract disorders. In Africa, previous studies have shown a relative rarity of this condition with a prevalence less than 5%; since it is between 2 and 5 times higher in other continents. A good knowledge of the profile of patient with gallstone disease in a surgical setting could allow to reduce gallstone disease complications and to tailor better the treatment. To our knowledge, there was no previous study about gallstone disease in this region even if there is a high prevalence of metabolic factors of gallstone disease.

Methods: This study objective is to describe the epidemiological, diagnostic and therapeutic profile of patients with gallstone disease at the Department of General Surgery of Saint-Louis Hospital (Senegal). It will be a single-centre retrospective cohort study in a period of 5 years (January 2015 - December 2020). The patients' record of the department of general surgery will be consulted and the patient contacted if there are missing data. Patients with gallstone disease diagnosed with imaging (ultrasonography and/or CT scan) regardless the presentation (asymptomatic, biliary colic, cholecystitis, common bile duct lithiasis, angio-cholitis, pancreatitis) will be included. Adults and paediatric patients will be enrolled. Patient records lacking sufficient data will be excluded. Studied parameters will be epidemiological, clinical, paraclinical and therapeutic aspects.

Ethics and dissemination: Anonymity and confidentiality of information collected in patients will be respected. This research protocol will be submitted to the Ethics Committee of our institution for approval. The knowledge of the profile of patients with gallstone disease in a surgical setting could allow to reduce gallstone disease complications and to tailor better the treatment. Finally, it will help to reduce the burden of gallstone disease.

Highlights: Gallstone disease is the most common biliary tract conditionTo our knowledge, there was no previous study about gallstone disease in this region even if there is a high prevalence of risk factors of gallstone disease (sickle cell disease, diabetes, obesity, hypercholesterolemia)Good knowledge of the profile of patients with gallstone disease in a surgical setting could allow to reduce gallstone disease complications and to tailor better the treatment.

简介:胆结石疾病是一种以胆道结石形成为特征的疾病。它是最常见的胆道疾病,占所有胆囊和胆道疾病的98%以上。在非洲,以前的研究表明这种情况相对罕见,患病率低于5%;因为在其他大陆,这个数字要高出2到5倍。在外科手术中,充分了解胆结石患者的特点可以减少胆结石并发症,更好地定制治疗方案。据我们所知,尽管该地区胆结石疾病的代谢因素非常普遍,但目前尚无关于该地区胆结石疾病的研究。方法:本研究的目的是描述塞内加尔圣路易医院普外科胆囊结石患者的流行病学、诊断和治疗概况。这将是一项为期5年(2015年1月至2020年12月)的单中心回顾性队列研究。查阅普外科患者病历,如有遗漏,与患者联系。无论表现如何(无症状、胆道绞痛、胆囊炎、胆总管结石症、血管胆管炎、胰腺炎),经影像学(超声检查和/或CT扫描)诊断为胆结石疾病的患者将被纳入研究范围。成人和儿科患者将被纳入研究。缺乏足够数据的患者记录将被排除在外。研究的参数将是流行病学、临床、临床辅助和治疗方面。伦理和传播:尊重患者信息的匿名性和保密性。本研究方案将提交我院伦理委员会批准。在外科手术中了解胆结石患者的特征可以减少胆结石并发症,更好地定制治疗方案。最后,它将有助于减轻胆结石疾病的负担。重点:胆结石疾病是最常见的胆道疾病,据我们所知,尽管胆结石疾病的危险因素(镰状细胞病、糖尿病、肥胖、高胆固醇血症)的患病率很高,但在该地区尚无关于胆结石疾病的研究。在手术环境中对胆结石疾病患者的概况有良好的了解,可以减少胆结石疾病的并发症并更好地定制治疗方案。
{"title":"Profile of Patients with Gallstone Disease in a Sub-Saharan African General Surgery Department: A Retrospective Cohort Study Protocol.","authors":"A Ndong,&nbsp;N F Gaye,&nbsp;J N Tendeng,&nbsp;M L Diao,&nbsp;A C Diallo,&nbsp;F G Niang,&nbsp;S Diop,&nbsp;D A Dia,&nbsp;M Diedhiou,&nbsp;M Dieng,&nbsp;M L Fall,&nbsp;P M Ma Nyemb,&nbsp;I Konaté","doi":"10.29337/ijsp.143","DOIUrl":"https://doi.org/10.29337/ijsp.143","url":null,"abstract":"<p><strong>Introduction: </strong>Gallstone disease is a disorder characterised by the formation of stones in the biliary tract. It is the most common biliary condition accounting for more than 98% of all gallbladder and biliary tract disorders. In Africa, previous studies have shown a relative rarity of this condition with a prevalence less than 5%; since it is between 2 and 5 times higher in other continents. A good knowledge of the profile of patient with gallstone disease in a surgical setting could allow to reduce gallstone disease complications and to tailor better the treatment. To our knowledge, there was no previous study about gallstone disease in this region even if there is a high prevalence of metabolic factors of gallstone disease.</p><p><strong>Methods: </strong>This study objective is to describe the epidemiological, diagnostic and therapeutic profile of patients with gallstone disease at the Department of General Surgery of Saint-Louis Hospital (Senegal). It will be a single-centre retrospective cohort study in a period of 5 years (January 2015 - December 2020). The patients' record of the department of general surgery will be consulted and the patient contacted if there are missing data. Patients with gallstone disease diagnosed with imaging (ultrasonography and/or CT scan) regardless the presentation (asymptomatic, biliary colic, cholecystitis, common bile duct lithiasis, angio-cholitis, pancreatitis) will be included. Adults and paediatric patients will be enrolled. Patient records lacking sufficient data will be excluded. Studied parameters will be epidemiological, clinical, paraclinical and therapeutic aspects.</p><p><strong>Ethics and dissemination: </strong>Anonymity and confidentiality of information collected in patients will be respected. This research protocol will be submitted to the Ethics Committee of our institution for approval. The knowledge of the profile of patients with gallstone disease in a surgical setting could allow to reduce gallstone disease complications and to tailor better the treatment. Finally, it will help to reduce the burden of gallstone disease.</p><p><strong>Highlights: </strong>Gallstone disease is the most common biliary tract conditionTo our knowledge, there was no previous study about gallstone disease in this region even if there is a high prevalence of risk factors of gallstone disease (sickle cell disease, diabetes, obesity, hypercholesterolemia)Good knowledge of the profile of patients with gallstone disease in a surgical setting could allow to reduce gallstone disease complications and to tailor better the treatment.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"61-65"},"PeriodicalIF":0.9,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol. 吉西他滨加nab -紫杉醇新辅助化疗方案治疗伴有动脉受损伤的边缘可切除胰腺癌:一项前瞻性多中心单组II期研究方案
IF 0.9 Q3 SURGERY Pub Date : 2021-04-26 DOI: 10.29337/ijsp.142
Yoshihiro Miyasaka, Takao Ohtsuka, Susumu Eguchi, Masafumi Inomata, Kazuyoshi Nishihara, Hiroyuki Shinchi, Koji Okuda, Hideo Baba, Hiroaki Nagano, Toshiharu Ueki, Hirokazu Noshiro, Masafumi Nakamura

Introduction: Although neoadjuvant treatment is recommended for patients with borderline resectable pancreatic cancer (BRPC), no standard neoadjuvant regimen has been established for BRPC with arterial involvement (BRPC-A), which is associated with a higher risk of margin-positive resection and poorer prognosis than BRPC with only venous involvement. Gemcitabine plus nab-paclitaxel (GnP) has been reported to significantly reduce tumor size in metastatic pancreatic cancer, and some retrospective studies suggested that neoadjuvant GnP for BRPC improved resectability and survival.

Methods and analysis: A prospective multicenter single-arm phase II study is conducted to evaluate the safety and efficacy of GnP as neoadjuvant chemotherapy for BRPC-A. The primary endpoint is the R0 resection rate. The secondary endpoints are the neoadjuvant chemotherapy response rate, resection rate, pathological response rate, incidence rate of adverse events, and quality of life.

Ethics and dissemination: This study protocol was approved by the institutional review board of Kyushu University (no. 181). The results will be published in a peer-reviewed journal and will be presented at medical meetings.

Highlights: Strategy for borderline resectable pancreatic cancer involving arteries (BRPC-A).There is no standard regimen for neoadjuvant chemotherapy for BRPC-A.Gemcitabine plus nab-paclitaxel (GnP) shows significant tumor shrinkage.Neoadjuvant GnP for BRPC-A increases resectability and margin-negative resection.

虽然推荐对交界性可切除胰腺癌(BRPC)患者进行新辅助治疗,但对于动脉受累的BRPC (BRPC- a)尚未建立标准的新辅助治疗方案,与仅静脉受累的BRPC相比,BRPC的边缘阳性切除风险更高,预后更差。据报道,吉西他滨加nab-紫杉醇(GnP)可显著降低转移性胰腺癌的肿瘤大小,一些回顾性研究表明,BRPC的新辅助GnP可提高可切除性和生存率。方法与分析:通过一项前瞻性多中心单臂II期研究来评估GnP作为BRPC-A新辅助化疗的安全性和有效性。主要终点是R0切除率。次要终点为新辅助化疗反应率、切除率、病理反应率、不良事件发生率和生活质量。伦理与传播:本研究方案已获得九州大学机构审查委员会批准(编号:014861)。181)。研究结果将发表在同行评议的期刊上,并将在医学会议上发表。重点:浸润动脉的交界性可切除胰腺癌(BRPC-A)的治疗策略。BRPC-A的新辅助化疗没有标准方案。吉西他滨联合nab-紫杉醇(GnP)显示肿瘤明显缩小。BRPC-A的新辅助GnP增加了可切除性和边缘阴性切除。
{"title":"Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol.","authors":"Yoshihiro Miyasaka,&nbsp;Takao Ohtsuka,&nbsp;Susumu Eguchi,&nbsp;Masafumi Inomata,&nbsp;Kazuyoshi Nishihara,&nbsp;Hiroyuki Shinchi,&nbsp;Koji Okuda,&nbsp;Hideo Baba,&nbsp;Hiroaki Nagano,&nbsp;Toshiharu Ueki,&nbsp;Hirokazu Noshiro,&nbsp;Masafumi Nakamura","doi":"10.29337/ijsp.142","DOIUrl":"https://doi.org/10.29337/ijsp.142","url":null,"abstract":"<p><strong>Introduction: </strong>Although neoadjuvant treatment is recommended for patients with borderline resectable pancreatic cancer (BRPC), no standard neoadjuvant regimen has been established for BRPC with arterial involvement (BRPC-A), which is associated with a higher risk of margin-positive resection and poorer prognosis than BRPC with only venous involvement. Gemcitabine plus nab-paclitaxel (GnP) has been reported to significantly reduce tumor size in metastatic pancreatic cancer, and some retrospective studies suggested that neoadjuvant GnP for BRPC improved resectability and survival.</p><p><strong>Methods and analysis: </strong>A prospective multicenter single-arm phase II study is conducted to evaluate the safety and efficacy of GnP as neoadjuvant chemotherapy for BRPC-A. The primary endpoint is the R0 resection rate. The secondary endpoints are the neoadjuvant chemotherapy response rate, resection rate, pathological response rate, incidence rate of adverse events, and quality of life.</p><p><strong>Ethics and dissemination: </strong>This study protocol was approved by the institutional review board of Kyushu University (no. 181). The results will be published in a peer-reviewed journal and will be presented at medical meetings.</p><p><strong>Highlights: </strong>Strategy for borderline resectable pancreatic cancer involving arteries (BRPC-A).There is no standard regimen for neoadjuvant chemotherapy for BRPC-A.Gemcitabine plus nab-paclitaxel (GnP) shows significant tumor shrinkage.Neoadjuvant GnP for BRPC-A increases resectability and margin-negative resection.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"55-60"},"PeriodicalIF":0.9,"publicationDate":"2021-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
RETention of urine After INguinal hernia Elective Repair (RETAINER study I and II). 腹股沟疝选择性修复术后尿潴留(保留研究I和II)。
IF 0.9 Q3 SURGERY Pub Date : 2021-04-23 DOI: 10.29337/ijsp.137
Stefanie M Croghan, Christina A Fleming, Helen M Mohan, Deena Harji, Jarlath C Bolger, Jessie A Elliott, Michael Boland, Peter E Lonergan, Patrick Dillon, David M Quinlan, Des C Winter

Purpose: Post-operative urinary retention (POUR) is a well-recognised complication of inguinal hernia repair (IHR). The magnitude of the problem is unclear, and contradictory evidence surrounds postulated risk factors. POUR risks patient distress, catheter-complications and a financial and logistical burden to services. Separately, in the field of IHR, there has been a lack of research into patients' perceptions of surgical 'success'. Our aim is to perform a two-phase, multi-centre prospective study to:Assess the rate, risk factors and impact related to POUR post IH repair.Develop and validate a patient reported outcome measure (PROM) for inguinal hernia repair.

Methods: RETAINER I: We propose a 24-week prospective study with voluntary international participation in 4 week blocks. All patients undergoing elective IH repair (minimally-invasive/open) will be eligible. Standardised data collection will include patient and perioperative factors. Primary outcome will be development of POUR, defined as the need for insertion of a urinary catheter as determined by the treating clinician. Secondary outcomes will be identification of factors predisposing to POUR and the impact of POUR.RETAINER II: A patient reported outcome measure will be developed using representative patient focus groups for item generation, from which an initial questionnaire will be developed and piloted. Validity, reliability, sensitivity and reproducibility will be assessed using the QQ-10 and standard psychometric methodology.

Conclusions: Using an international multicentre collaborative approach will produce the necessary volume of patients, whilst capturing inter-centre variability, to accurately reflect POUR rates and allow analysis of risk factors. This patient pool will provide an excellent opportunity to develop a PROM using appropriate qualitative methodology.

Highlights retainer i & ii protocols: RETAINER (RETention of urine After INguinal hernia Elective Repair) I is a prospective, multicentre, international observational study.RETAINER I aims to explore the incidence of and risk factors for urinary retention following elective inguinal hernia repair.Urinary retention following inguinal hernia repair has a marked impact on patients and creates a significant financial and logistical burden for hospital services.RETAINER II is a prospective, qualitative study, recruiting patients to guide the creation of a patient-reported outcome measure (PROM) for elective inguinal hernia repair.

目的:术后尿潴留(POUR)是腹股沟疝修补术(IHR)的常见并发症。这个问题的严重程度尚不清楚,围绕着假定的风险因素的证据相互矛盾。POUR有患者窘迫、导管并发症以及服务的财政和后勤负担的风险。另外,在《国际卫生条例》领域,缺乏对患者对手术“成功”的看法的研究。我们的目标是进行一项两阶段、多中心的前瞻性研究,以评估IH后POUR修复的发生率、风险因素和影响。开发和验证腹股沟疝修补的患者报告结果测量(PROM)。方法:保留I:我们提出了一项为期24周的前瞻性研究,国际自愿参与,为期4周。所有接受选择性IH修复(微创/开放)的患者都符合条件。标准化的数据收集将包括患者和围手术期因素。主要结局将是尿潴留的发展,定义为由治疗的临床医生确定是否需要插入导尿管。次要结果将是确定诱发POUR的因素和POUR的影响。保留II:将使用具有代表性的患者焦点小组进行项目生成,开发患者报告的结果测量,并从中开发和试点初始问卷。效度、信度、灵敏度和可重复性将使用QQ-10和标准心理测量方法进行评估。结论:采用国际多中心合作方法将产生必要的患者数量,同时捕获中心间的可变性,以准确反映POUR率并允许分析风险因素。这个病人池将提供一个极好的机会,以开发PROM使用适当的定性方法。保留器i和ii方案:保留器(腹股沟疝选择性修复后尿潴留)i是一项前瞻性、多中心、国际观察性研究。retention I旨在探讨选择性腹股沟疝修补术后尿潴留的发生率和危险因素。腹股沟疝修补术后尿潴留对患者有显著影响,并对医院服务造成重大的财政和后勤负担。RETAINER II是一项前瞻性定性研究,招募患者来指导选择性腹股沟疝修补术患者报告结果测量(PROM)的创建。
{"title":"RETention of urine After INguinal hernia Elective Repair (RETAINER study I and II).","authors":"Stefanie M Croghan,&nbsp;Christina A Fleming,&nbsp;Helen M Mohan,&nbsp;Deena Harji,&nbsp;Jarlath C Bolger,&nbsp;Jessie A Elliott,&nbsp;Michael Boland,&nbsp;Peter E Lonergan,&nbsp;Patrick Dillon,&nbsp;David M Quinlan,&nbsp;Des C Winter","doi":"10.29337/ijsp.137","DOIUrl":"https://doi.org/10.29337/ijsp.137","url":null,"abstract":"<p><strong>Purpose: </strong>Post-operative urinary retention (POUR) is a well-recognised complication of inguinal hernia repair (IHR). The magnitude of the problem is unclear, and contradictory evidence surrounds postulated risk factors. POUR risks patient distress, catheter-complications and a financial and logistical burden to services. Separately, in the field of IHR, there has been a lack of research into patients' perceptions of surgical 'success'. Our aim is to perform a two-phase, multi-centre prospective study to:Assess the rate, risk factors and impact related to POUR post IH repair.Develop and validate a patient reported outcome measure (PROM) for inguinal hernia repair.</p><p><strong>Methods: </strong>RETAINER I: We propose a 24-week prospective study with voluntary international participation in 4 week blocks. All patients undergoing elective IH repair (minimally-invasive/open) will be eligible. Standardised data collection will include patient and perioperative factors. Primary outcome will be development of POUR, defined as the need for insertion of a urinary catheter as determined by the treating clinician. Secondary outcomes will be identification of factors predisposing to POUR and the impact of POUR.RETAINER II: A patient reported outcome measure will be developed using representative patient focus groups for item generation, from which an initial questionnaire will be developed and piloted. Validity, reliability, sensitivity and reproducibility will be assessed using the QQ-10 and standard psychometric methodology.</p><p><strong>Conclusions: </strong>Using an international multicentre collaborative approach will produce the necessary volume of patients, whilst capturing inter-centre variability, to accurately reflect POUR rates and allow analysis of risk factors. This patient pool will provide an excellent opportunity to develop a PROM using appropriate qualitative methodology.</p><p><strong>Highlights retainer i & ii protocols: </strong>RETAINER (RETention of urine After INguinal hernia Elective Repair) I is a prospective, multicentre, international observational study.RETAINER I aims to explore the <i>incidence of</i> and <i>risk factors for</i> urinary retention following elective inguinal hernia repair.Urinary retention following inguinal hernia repair has a marked impact on patients and creates a significant financial and logistical burden for hospital services.RETAINER II is a prospective, qualitative study, recruiting patients to guide the creation of a patient-reported outcome measure (PROM) for elective inguinal hernia repair.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"42-54"},"PeriodicalIF":0.9,"publicationDate":"2021-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial. 评价ReHub在初次全膝关节置换术患者中的安全性和有效性:一项随机对照试验的研究方案。
IF 0.9 Q3 SURGERY Pub Date : 2021-04-19 DOI: 10.29337/ijsp.138
Montse Nuevo, Hadis Mahdavi, Daniel Rodríguez, Teresa Faura, Núria Fabrellas, Simone Balocco, Marco Conti, Alessandro Castagna, Salvi Prat

Background: Total Knee Arthroplasty (TKA) is an intervention that can significantly improve the quality of life of patients with advanced knee osteoarthritis. Early start of rehabilitation and its continuation at home once the patient is discharged are key factors for the success of the process.This study aims to assess the effectiveness of a home-based telerehabilitation solution (ReHub) on improving functional capacity and clinical outcomes for patients who underwent TKA.

Methods/design: The study is a randomized, open-label with blinded outcome assessor, parallel assignment clinical trial with a sample size of 52 patients that is conducted according to the SPIRIT recommendations. After the TKA intervention, the patients are randomly allocated to the control group or the experimental group with a 1:1 ratio. Both groups follow a Fast Track recovery protocol which includes discharge after 2-3 days from surgery, a daily plan of 5 exercises for autonomous rehabilitation and domiciliary visits by a physiotherapist starting approximately 2 weeks after surgery. The experimental group uses the sensor-based telerehabilitation system ReHub to perform the exercises. The primary outcome measure is the range of motion of the knee. Secondary outcomes include physical performance, quality of life, pain intensity, muscle strength, treatment adherence and satisfaction with the ReHub system. The outcomes assessment is performed at hospital discharge (baseline), at stitch removal (2 weeks after baseline) and 2 weeks after stitch removal (4 weeks after baseline).The study conforms to the guidelines of the Declaration of Helsinki and was approved by the hospital's ethics committee.

Discussion: The study will address an important gap in the evidence base by reporting the effectiveness of an affordable and low-cost home-based telerehabilitation solution in patients who underwent TKA.

Ethics and dissemination: The study was approved by the hospital's ethics committee ("Comité Ético de Investigación Clínica del HCB", reg. HCB/2019/0571). The trial was registred at ClinicalTrials.gov (NCT04155957). The results of this study will be published in peer-reviewed journals as well as national and international conferences.

Trial registration: NCT04155957 (ClinicalTrials.gov).

Highlights: Assessing a home-based telerehabilitation solution effectiveness in knee surgery.In situations such as the CoVid-19 pandemic, it is a resolutive intervention method.Telerehabilitation is an alternative to conventional face-to-face physical therapy.This system is far less demanding in terms of human resources.Range of motion assessment is the primary outcome measure.

背景:全膝关节置换术(TKA)是一种可以显著改善晚期膝关节骨关节炎患者生活质量的干预措施。患者出院后尽早开始康复并在家中继续康复是康复过程成功的关键因素。本研究旨在评估基于家庭的远程康复解决方案(ReHub)在改善TKA患者功能能力和临床结果方面的有效性。方法/设计:该研究是一项随机、开放标签、盲法结局评估、平行分配临床试验,样本量为52例患者,根据SPIRIT推荐进行。经TKA干预后,将患者按1:1的比例随机分为对照组和实验组。两组患者都遵循快速康复方案,包括术后2-3天后出院,每天5次自主康复锻炼计划,以及术后约2周开始由物理治疗师上门就诊。实验组使用基于传感器的远程康复系统ReHub进行练习。主要的结果测量是膝关节的活动范围。次要结局包括身体表现、生活质量、疼痛强度、肌肉力量、治疗依从性和对ReHub系统的满意度。结果评估在出院(基线)、拆线(基线后2周)和拆线后2周(基线后4周)进行。这项研究符合赫尔辛基宣言的指导方针,并得到了医院伦理委员会的批准。讨论:该研究将通过报告可负担和低成本的家庭远程康复解决方案对接受TKA的患者的有效性来解决证据基础上的一个重要空白。伦理和传播:该研究得到了医院伦理委员会(“comit Ético de Investigación Clínica del HCB”,reg)的批准。六氯苯/ 2019/0571)。该试验已在ClinicalTrials.gov注册(NCT04155957)。这项研究的结果将发表在同行评议的期刊以及国内和国际会议上。试验注册:NCT04155957 (ClinicalTrials.gov)。重点:评估基于家庭的远程康复解决方案在膝关节手术中的有效性。在CoVid-19大流行等情况下,这是一种果断的干预方法。远程康复是传统面对面物理治疗的另一种选择。这种制度对人力资源的要求要低得多。活动范围评估是主要的预后指标。
{"title":"Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial.","authors":"Montse Nuevo,&nbsp;Hadis Mahdavi,&nbsp;Daniel Rodríguez,&nbsp;Teresa Faura,&nbsp;Núria Fabrellas,&nbsp;Simone Balocco,&nbsp;Marco Conti,&nbsp;Alessandro Castagna,&nbsp;Salvi Prat","doi":"10.29337/ijsp.138","DOIUrl":"https://doi.org/10.29337/ijsp.138","url":null,"abstract":"<p><strong>Background: </strong>Total Knee Arthroplasty (TKA) is an intervention that can significantly improve the quality of life of patients with advanced knee osteoarthritis. Early start of rehabilitation and its continuation at home once the patient is discharged are key factors for the success of the process.This study aims to assess the effectiveness of a home-based telerehabilitation solution (ReHub) on improving functional capacity and clinical outcomes for patients who underwent TKA.</p><p><strong>Methods/design: </strong>The study is a randomized, open-label with blinded outcome assessor, parallel assignment clinical trial with a sample size of 52 patients that is conducted according to the SPIRIT recommendations. After the TKA intervention, the patients are randomly allocated to the control group or the experimental group with a 1:1 ratio. Both groups follow a Fast Track recovery protocol which includes discharge after 2-3 days from surgery, a daily plan of 5 exercises for autonomous rehabilitation and domiciliary visits by a physiotherapist starting approximately 2 weeks after surgery. The experimental group uses the sensor-based telerehabilitation system ReHub to perform the exercises. The primary outcome measure is the range of motion of the knee. Secondary outcomes include physical performance, quality of life, pain intensity, muscle strength, treatment adherence and satisfaction with the ReHub system. The outcomes assessment is performed at hospital discharge (baseline), at stitch removal (2 weeks after baseline) and 2 weeks after stitch removal (4 weeks after baseline).The study conforms to the guidelines of the Declaration of Helsinki and was approved by the hospital's ethics committee.</p><p><strong>Discussion: </strong>The study will address an important gap in the evidence base by reporting the effectiveness of an affordable and low-cost home-based telerehabilitation solution in patients who underwent TKA.</p><p><strong>Ethics and dissemination: </strong>The study was approved by the hospital's ethics committee (\"Comité Ético de Investigación Clínica del HCB\", reg. HCB/2019/0571). The trial was registred at ClinicalTrials.gov (NCT04155957). The results of this study will be published in peer-reviewed journals as well as national and international conferences.</p><p><strong>Trial registration: </strong>NCT04155957 (ClinicalTrials.gov).</p><p><strong>Highlights: </strong>Assessing a home-based telerehabilitation solution effectiveness in knee surgery.In situations such as the CoVid-19 pandemic, it is a resolutive intervention method.Telerehabilitation is an alternative to conventional face-to-face physical therapy.This system is far less demanding in terms of human resources.Range of motion assessment is the primary outcome measure.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"34-41"},"PeriodicalIF":0.9,"publicationDate":"2021-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Novel Mixed-Methods Platform Study Protocol for Investigating New Surgical Devices, with Embedded Shared Learning: Ibra-net Breast Lesion Localisation Study. 一种新型混合方法平台研究方案,用于研究新型手术设备,具有嵌入式共享学习:Ibra-net乳房病变定位研究。
IF 0.9 Q3 SURGERY Pub Date : 2021-04-16 DOI: 10.29337/ijsp.136
Hannah L Bromley, Rajiv Dave, Chris Holcombe, Shelley Potter, Anthony J Maxwell, Cliona Kirwan, Senthurun Mylvaganam, Suzanne Elgammal, Jenna Morgan, Sue Down, Tahir Masudi, Amtul Sami, Nicola Barnes, James Harvey
<p><strong>Introduction: </strong>New medical devices must have adequate research, such that outcomes are known, enabling patients to be consented with knowledge of the safety and efficacy of the device to be implanted. Device trials are challenging due to the learning curve and iterative assessment of best practice. This study is designed to pilot a national collaborative approach to medical device introduction by breast surgeons in the UK, using breast localisation devices as an exemplar. The aim is to develop an effective and transferable surgical device platform protocol design, with embedded shared learning.</p><p><strong>Methods and analysis: </strong>The iBRA-net localisation study is a UK based prospective, multi-centre platform study, comparing the safety and efficacy of novel localisation devices with wire-guided breast lesion localisation for wide local excision, using Magseed® as the pilot intervention group. Centres performing breast lesion localisation for wide local excision or excision biopsy will be eligible to participate if using one of the included devices. Further intervention arms will be added as new devices are CE marked. Outcomes will be collected via an online database. The primary outcome measure will be identification of the index lesion. Participating surgeons will be asked to record shared learning events via online questionnaires and focus group interviews to inform future study arms.</p><p><strong>Ethics and dissemination: </strong>The study will aim to collect data on 950 procedures for each intervention (Magseed® and wire localisation) from UK breast centres over an 18-month period. Shared learning will be prospectively evaluated via thematic analysis to refine breast localisation technique and to promote early identification of potential pitfalls and problems. Results will be presented at national and international conferences and published in peer reviewed journals.</p><p><strong>Registration: </strong>This is a UK national audit registered with Manchester University NHS Foundation Trust.</p><p><strong>Highlights: </strong>This protocol outlines a novel methodology for a collaborative national platform study to collate safety and efficacy data on new medical devices. Improved registration and audit of new medical devices is a major theme of the Cumberlege report of the Independent Medicines and Medical Devices Safety Review.We outline a protocol for a UK based multi-centre prospective audit to investigate the safety and efficacy of new surgical devices for breast lesion localisation. The study will run as a platform study using wire localisation as a control group and Magseed® as the first intervention arm.The protocol is designed for additional bolt-on intervention arms for other localisation devices, such as Hologic Localizer™ and Savi Scout®, when they become available to the European market. This will enable comparison of these devices to datasets already collected on wire and Magseed® localisation.The stud
导言:新的医疗器械必须有充分的研究,这样的结果是已知的,使患者同意了解植入设备的安全性和有效性。由于学习曲线和最佳实践的迭代评估,设备试验具有挑战性。本研究的目的是试点一个国家合作的方法,以医疗设备引进乳房外科医生在英国,使用乳房定位装置为例。目的是开发一种有效的、可转移的手术器械平台协议设计,并嵌入共享学习。方法和分析:iBRA-net定位研究是一项基于英国的前瞻性,多中心平台研究,比较新型定位装置与线导乳房病变定位的安全性和有效性,用于广泛的局部切除,使用Magseed®作为试点干预组。如果使用其中一种设备,进行乳房病变定位进行广泛局部切除或切除活检的中心将有资格参加。随着新设备获得CE标志,将增加进一步的干预臂。结果将通过在线数据库收集。主要的结果测量将是主要病变的识别。参与的外科医生将被要求通过在线问卷和焦点小组访谈记录共享的学习事件,以告知未来的研究部门。伦理和传播:该研究旨在收集来自英国乳腺中心的950例干预(Magseed®和钢丝定位)的数据,为期18个月。将通过专题分析对共享学习进行前瞻性评估,以改进乳房定位技术,并促进早期识别潜在的陷阱和问题。研究结果将在国内和国际会议上发表,并发表在同行评议的期刊上。注册:这是在曼彻斯特大学NHS基金会信托基金注册的英国国家审计。重点:本协议概述了一种新的方法,用于国家合作平台研究,以整理新医疗器械的安全性和有效性数据。改进新医疗器械的注册和审核是独立药品和医疗器械安全审查的Cumberlege报告的一个主要主题。我们概述了一项基于英国的多中心前瞻性审计的协议,以调查用于乳房病变定位的新手术设备的安全性和有效性。该研究将作为一个平台研究,使用导线定位作为对照组,Magseed®作为第一个干预组。该协议旨在为其他定位设备(如Hologic Localizer™和Savi Scout®)提供额外的螺栓式干预臂,当它们在欧洲市场上市时。这将使这些设备与已经在wire和Magseed®本地化上收集的数据集进行比较。该研究包括一种新的共享学习方法,使用迭代在线数据库报告和外科访谈来集中分发有关学习事件、关键治理问题和未来使用的推荐协议的信息。
{"title":"A Novel Mixed-Methods Platform Study Protocol for Investigating New Surgical Devices, with Embedded Shared Learning: Ibra-net Breast Lesion Localisation Study.","authors":"Hannah L Bromley,&nbsp;Rajiv Dave,&nbsp;Chris Holcombe,&nbsp;Shelley Potter,&nbsp;Anthony J Maxwell,&nbsp;Cliona Kirwan,&nbsp;Senthurun Mylvaganam,&nbsp;Suzanne Elgammal,&nbsp;Jenna Morgan,&nbsp;Sue Down,&nbsp;Tahir Masudi,&nbsp;Amtul Sami,&nbsp;Nicola Barnes,&nbsp;James Harvey","doi":"10.29337/ijsp.136","DOIUrl":"https://doi.org/10.29337/ijsp.136","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;New medical devices must have adequate research, such that outcomes are known, enabling patients to be consented with knowledge of the safety and efficacy of the device to be implanted. Device trials are challenging due to the learning curve and iterative assessment of best practice. This study is designed to pilot a national collaborative approach to medical device introduction by breast surgeons in the UK, using breast localisation devices as an exemplar. The aim is to develop an effective and transferable surgical device platform protocol design, with embedded shared learning.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods and analysis: &lt;/strong&gt;The iBRA-net localisation study is a UK based prospective, multi-centre platform study, comparing the safety and efficacy of novel localisation devices with wire-guided breast lesion localisation for wide local excision, using Magseed® as the pilot intervention group. Centres performing breast lesion localisation for wide local excision or excision biopsy will be eligible to participate if using one of the included devices. Further intervention arms will be added as new devices are CE marked. Outcomes will be collected via an online database. The primary outcome measure will be identification of the index lesion. Participating surgeons will be asked to record shared learning events via online questionnaires and focus group interviews to inform future study arms.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Ethics and dissemination: &lt;/strong&gt;The study will aim to collect data on 950 procedures for each intervention (Magseed® and wire localisation) from UK breast centres over an 18-month period. Shared learning will be prospectively evaluated via thematic analysis to refine breast localisation technique and to promote early identification of potential pitfalls and problems. Results will be presented at national and international conferences and published in peer reviewed journals.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Registration: &lt;/strong&gt;This is a UK national audit registered with Manchester University NHS Foundation Trust.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Highlights: &lt;/strong&gt;This protocol outlines a novel methodology for a collaborative national platform study to collate safety and efficacy data on new medical devices. Improved registration and audit of new medical devices is a major theme of the Cumberlege report of the Independent Medicines and Medical Devices Safety Review.We outline a protocol for a UK based multi-centre prospective audit to investigate the safety and efficacy of new surgical devices for breast lesion localisation. The study will run as a platform study using wire localisation as a control group and Magseed® as the first intervention arm.The protocol is designed for additional bolt-on intervention arms for other localisation devices, such as Hologic Localizer™ and Savi Scout®, when they become available to the European market. This will enable comparison of these devices to datasets already collected on wire and Magseed® localisation.The stud","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"26-33"},"PeriodicalIF":0.9,"publicationDate":"2021-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Clinical Effectiveness of Various Surgical Procedures Addressing Long Head of Biceps Pathology: Protocol for a Systematic Review and Meta-Analysis. 治疗肱二头肌长头病变的各种外科手术的临床效果:系统回顾和荟萃分析方案。
IF 0.9 Q3 SURGERY Pub Date : 2021-04-13 DOI: 10.29337/ijsp.139
Alexander W Hartland, Raisa Islam, Kar H Teoh, Mustafa S Rashid

Introduction: The long head of biceps tendon is a common source of anterior shoulder pain and impaired function. Multiple surgical procedures are available as treatment options, but the optimal procedure is not known. The aim of this systematic review and meta-analysis is to review the literature to assess the clinical effectiveness of various surgical procedures to treat pain arising from the long head of biceps.

Methods: The study protocol was designed and registered prospectively on PROSPERO (International prospective register for systematic reviews). Electronic databases used for the literature search will include MEDLINE, EMBASE, PsycINFO, and The Cochrane Library. Randomised controlled trials (RCTs) evaluating surgical procedures on the long head of biceps will be included. Our primary outcome is any functional patient-reported outcome measure related to the shoulder. Secondary outcomes will include the rate of 'Popeye' deformity, the rate of biceps cramping pain, the rate of complications, objective measurements of strength testing such as dynamometer, and other patient-reported outcome measures not specific to the shoulder such as the Visual-Analog Scale (VAS) for pain. Methodological quality of included studies will be assessed using The Cochrane Risk of Bias Tool 2.0 and the Jadad score. Inconsistency and bias across included studies will be assessed statistically. Comparable outcome data will be pooled and analysed quantitatively or qualitatively as appropriate.

Ethics and dissemination: No ethical clearances required for this study. We plan to publish this systematic review and meta-analysis in a peer-reviewed journal. It will also be presented at various national and international conferences.

Highlights: Evaluating the clinical effectiveness of surgical procedures for long head of biceps pathology.Randomised controlled trials.Biceps tenodesis and biceps tenotomy.Systematic review compliant with the PRISMA guideline.

简介:二头肌肌腱的长头是肩前疼痛和功能受损的常见原因。多种外科手术可作为治疗选择,但最佳手术尚不清楚。本系统综述和荟萃分析的目的是回顾文献,以评估各种外科手术治疗二头肌长头疼痛的临床效果。方法:设计研究方案,并在PROSPERO(国际前瞻性系统评价注册系统)上进行前瞻性注册。用于文献检索的电子数据库包括MEDLINE、EMBASE、PsycINFO和Cochrane Library。随机对照试验(rct)评估二头肌长头的外科手术程序将包括在内。我们的主要终点是任何功能性患者报告的与肩部相关的终点测量。次要结果将包括“大力水手”畸形率、二头肌痉挛疼痛率、并发症率、力量测试的客观测量,如测力计,以及其他患者报告的非特定于肩部的结果测量,如疼痛的视觉模拟量表(VAS)。纳入研究的方法学质量将使用Cochrane风险偏倚工具2.0和Jadad评分进行评估。纳入研究的不一致性和偏倚将进行统计学评估。将汇集可比较的结果数据,并酌情进行定量或定性分析。伦理与传播:本研究不需要伦理许可。我们计划在同行评议的期刊上发表这一系统综述和荟萃分析。它还将在各种国家和国际会议上发表。重点:评价二头肌长头病变外科手术的临床效果。随机对照试验。二头肌肌腱固定术和二头肌肌腱切断术。系统评审符合PRISMA指南。
{"title":"Clinical Effectiveness of Various Surgical Procedures Addressing Long Head of Biceps Pathology: Protocol for a Systematic Review and Meta-Analysis.","authors":"Alexander W Hartland,&nbsp;Raisa Islam,&nbsp;Kar H Teoh,&nbsp;Mustafa S Rashid","doi":"10.29337/ijsp.139","DOIUrl":"https://doi.org/10.29337/ijsp.139","url":null,"abstract":"<p><strong>Introduction: </strong>The long head of biceps tendon is a common source of anterior shoulder pain and impaired function. Multiple surgical procedures are available as treatment options, but the optimal procedure is not known. The aim of this systematic review and meta-analysis is to review the literature to assess the clinical effectiveness of various surgical procedures to treat pain arising from the long head of biceps.</p><p><strong>Methods: </strong>The study protocol was designed and registered prospectively on PROSPERO (International prospective register for systematic reviews). Electronic databases used for the literature search will include MEDLINE, EMBASE, PsycINFO, and The Cochrane Library. Randomised controlled trials (RCTs) evaluating surgical procedures on the long head of biceps will be included. Our primary outcome is any functional patient-reported outcome measure related to the shoulder. Secondary outcomes will include the rate of 'Popeye' deformity, the rate of biceps cramping pain, the rate of complications, objective measurements of strength testing such as dynamometer, and other patient-reported outcome measures not specific to the shoulder such as the Visual-Analog Scale (VAS) for pain. Methodological quality of included studies will be assessed using The Cochrane Risk of Bias Tool 2.0 and the Jadad score. Inconsistency and bias across included studies will be assessed statistically. Comparable outcome data will be pooled and analysed quantitatively or qualitatively as appropriate.</p><p><strong>Ethics and dissemination: </strong>No ethical clearances required for this study. We plan to publish this systematic review and meta-analysis in a peer-reviewed journal. It will also be presented at various national and international conferences.</p><p><strong>Highlights: </strong>Evaluating the clinical effectiveness of surgical procedures for long head of biceps pathology.Randomised controlled trials.Biceps tenodesis and biceps tenotomy.Systematic review compliant with the PRISMA guideline.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"21-25"},"PeriodicalIF":0.9,"publicationDate":"2021-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Factors Associated with Foot Lesions in Diabetic Patients at Saint-Louis Hospital (Senegal): A Case-Control Study Protocol. 圣路易医院(塞内加尔)糖尿病患者足部病变相关因素:病例对照研究方案
IF 0.9 Q3 SURGERY Pub Date : 2021-04-09 DOI: 10.29337/ijsp.141
A Ndong, B Konta, J N Tendeng, D G Dia, A D Dia, M L Diao, A C Diallo, S Diop, B M Gouamba, D A Dia, M Diedhiou, M Dieng, M L Fall, P M Ma Nyemb, I Konaté

Introduction: Diabetes prevalence has increased over the past years. In Senegal, this prevalence is 4% in the general population. However, the region of Saint-Louis (in the north of the country) has the highest rate with 10.4%. The main prognosis problem is the occurrence foot lesions that can lead to lower-limbs amputation. Diabetic foot is a real public health issue, due to its economic burden and its serious repercussions on patients, leading to poor quality of life. The objective of this case-control study is to identify factors associated with foot lesions in diabetic patients.

Methods and analysis: It will be a case-control study from January to December 2021. The patients will be recruited from the departments of general surgery, internal medicine, and emergency. An univariate then multivariate analysis (logistic regression) will allow us to select the variables associated with foot lesions in our study population. The parameters included in the logistic regression will be those with a p < 0.20 in the univariate analysis. Finally, a binary logistic regression analysis (with the calculation of Odds Ratios (OR) with confidence intervals (CI)) according to the backward stepwise method will identify the factors independently associated to foot lesions in diabetic patients.

Ethics and dissemination: This research protocol will be submitted to the Ethics Committee of our institution for approval. The knowledge of factors causing diabetic foot will help to communicate with policymakers to raise the awareness in our community. Finally, it will help to prevent lower limb amputations.

Highlights: Diabetes is the leading cause of non-traumatic lower-limb amputation in the world.The region of Saint-Louis (Senegal) has the highest prevalence of diabetes.Controlling factors associated with foot lesions in diabetic patients can prevent from amputation.

导读:糖尿病患病率在过去几年有所增加。在塞内加尔,这一患病率在一般人群中为4%。然而,圣路易地区(在该国北部)的比例最高,为10.4%。主要的预后问题是发生足部病变,可导致下肢截肢。糖尿病足是一个真正的公共卫生问题,因为它的经济负担和对患者的严重影响,导致生活质量差。本病例对照研究的目的是确定与糖尿病患者足部病变相关的因素。方法与分析:2021年1月- 12月为病例对照研究。患者将从普外科、内科和急诊科招募。单变量和多变量分析(逻辑回归)将允许我们在研究人群中选择与足部病变相关的变量。逻辑回归的参数将是单变量分析中p < 0.20的参数。最后,根据后向逐步法进行二元logistic回归分析(计算比值比(OR)和置信区间(CI)),确定与糖尿病患者足部病变独立相关的因素。伦理与传播:本研究方案将提交本机构伦理委员会批准。了解导致糖尿病足的因素将有助于与决策者沟通,以提高我们社区的认识。最后,它将有助于防止下肢截肢。重点:糖尿病是世界上非创伤性下肢截肢的主要原因。圣路易(塞内加尔)地区的糖尿病患病率最高。糖尿病患者足部病变的控制因素可预防截肢。
{"title":"Factors Associated with Foot Lesions in Diabetic Patients at Saint-Louis Hospital (Senegal): A Case-Control Study Protocol.","authors":"A Ndong,&nbsp;B Konta,&nbsp;J N Tendeng,&nbsp;D G Dia,&nbsp;A D Dia,&nbsp;M L Diao,&nbsp;A C Diallo,&nbsp;S Diop,&nbsp;B M Gouamba,&nbsp;D A Dia,&nbsp;M Diedhiou,&nbsp;M Dieng,&nbsp;M L Fall,&nbsp;P M Ma Nyemb,&nbsp;I Konaté","doi":"10.29337/ijsp.141","DOIUrl":"https://doi.org/10.29337/ijsp.141","url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes prevalence has increased over the past years. In Senegal, this prevalence is 4% in the general population. However, the region of Saint-Louis (in the north of the country) has the highest rate with 10.4%. The main prognosis problem is the occurrence foot lesions that can lead to lower-limbs amputation. Diabetic foot is a real public health issue, due to its economic burden and its serious repercussions on patients, leading to poor quality of life. The objective of this case-control study is to identify factors associated with foot lesions in diabetic patients.</p><p><strong>Methods and analysis: </strong>It will be a case-control study from January to December 2021. The patients will be recruited from the departments of general surgery, internal medicine, and emergency. An univariate then multivariate analysis (logistic regression) will allow us to select the variables associated with foot lesions in our study population. The parameters included in the logistic regression will be those with a p < 0.20 in the univariate analysis. Finally, a binary logistic regression analysis (with the calculation of Odds Ratios (OR) with confidence intervals (CI)) according to the backward stepwise method will identify the factors independently associated to foot lesions in diabetic patients.</p><p><strong>Ethics and dissemination: </strong>This research protocol will be submitted to the Ethics Committee of our institution for approval. The knowledge of factors causing diabetic foot will help to communicate with policymakers to raise the awareness in our community. Finally, it will help to prevent lower limb amputations.</p><p><strong>Highlights: </strong>Diabetes is the leading cause of non-traumatic lower-limb amputation in the world.The region of Saint-Louis (Senegal) has the highest prevalence of diabetes.Controlling factors associated with foot lesions in diabetic patients can prevent from amputation.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"16-20"},"PeriodicalIF":0.9,"publicationDate":"2021-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38918219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-Emptive Endoluminal Negative Pressure Therapy at the Anastomotic Site in Minimally Invasive Transthoracic Esophagectomy (the preSPONGE Trial): Study Protocol for a Multicenter Randomized Controlled Trial. 微创经胸食管切除术吻合口处先发制人的腔内负压治疗(海绵前试验):一项多中心随机对照试验的研究方案
IF 0.9 Q3 SURGERY Pub Date : 2021-03-18 DOI: 10.29337/ijsp.24
Philip C Müller, Diana Vetter, Joshua R Kapp, Christoph Gubler, Bernhard Morell, Dimitri A Raptis, Christian A Gutschow

Introduction: Anastomotic leakage (AL) accounts for a significant proportion of morbidity following oesophagectomy. Endoluminal negative pressure (ENP) therapy via a specifically designed polyurethane foam (EsoSponge®, B.Braun Medical, Melsungen, Germany) has become the standard of care for AL in many specialized centres. The prophylactic (pENP) application of this technique aims to reduce postoperative morbidity and is a novel approach which has not yet been investigated in a prospective study. The aim of this study is therefore to assess the effect of pENP at the anastomotic site in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy.

Methods and analysis: The study design is a prospective, multi-centre, two-arm, parallel-group, randomised controlled trial and will be conducted in two phases. Phase one is a randomised feasibility and safety pilot trial involving 40 consecutive patients. After definitive sample size calculation, additional patients will be included accordingly during phase two. The primary outcome of the study will be the postoperative length of hospitalization until reaching previously defined "fit for discharge criteria". Secondary outcomes will include postoperative morbidity, mortality and postoperative AL-rates based on 90-day follow-up. A confirmatory analysis based on intention-to-treat will be performed.

Ethics and dissemination: The ethics committee of the University of Zurich approved this study (2019-00562), which has been registered with ClinicalTrials.gov on 14.11.2019 (NCT04162860) and the Swiss National Clinical Trials Portal (SNCTP000003524). The results of the study will be published and presented at appropriate conferences.

前言:吻合口漏(AL)在食管切除术后的发病率中占相当大的比例。通过专门设计的聚氨酯泡沫(EsoSponge®,B.Braun Medical, Melsungen, Germany)进行腔内负压(ENP)治疗已成为许多专业中心治疗AL的标准方法。该技术的预防性(pENP)应用旨在减少术后发病率,是一种尚未在前瞻性研究中进行调查的新方法。因此,本研究的目的是评估微创经胸Ivor Lewis食管切除术高危患者吻合口处pENP的效果。方法与分析:本研究设计为前瞻性、多中心、双臂、平行组、随机对照试验,将分为两个阶段进行。第一阶段是一项随机可行性和安全性试点试验,涉及40名连续患者。在确定样本量计算后,将在第二阶段纳入相应的额外患者。该研究的主要结果将是术后住院时间,直到达到先前定义的“适合出院标准”。次要结局包括术后发病率、死亡率和术后90天随访的al率。将进行基于意向治疗的确认性分析。伦理和传播:苏黎世大学伦理委员会批准了这项研究(2019-00562),该研究已于2019年11月14日在ClinicalTrials.gov (NCT04162860)和瑞士国家临床试验门户网站(SNCTP000003524)注册。这项研究的结果将在适当的会议上发表和提出。
{"title":"Pre-Emptive Endoluminal Negative Pressure Therapy at the Anastomotic Site in Minimally Invasive Transthoracic Esophagectomy (the preSPONGE Trial): Study Protocol for a Multicenter Randomized Controlled Trial.","authors":"Philip C Müller,&nbsp;Diana Vetter,&nbsp;Joshua R Kapp,&nbsp;Christoph Gubler,&nbsp;Bernhard Morell,&nbsp;Dimitri A Raptis,&nbsp;Christian A Gutschow","doi":"10.29337/ijsp.24","DOIUrl":"https://doi.org/10.29337/ijsp.24","url":null,"abstract":"<p><strong>Introduction: </strong>Anastomotic leakage (AL) accounts for a significant proportion of morbidity following oesophagectomy. Endoluminal negative pressure (ENP) therapy via a specifically designed polyurethane foam (EsoSponge<sup>®</sup>, B.Braun Medical, Melsungen, Germany) has become the standard of care for AL in many specialized centres. The prophylactic (pENP) application of this technique aims to reduce postoperative morbidity and is a novel approach which has not yet been investigated in a prospective study. The aim of this study is therefore to assess the effect of pENP at the anastomotic site in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy.</p><p><strong>Methods and analysis: </strong>The study design is a prospective, multi-centre, two-arm, parallel-group, randomised controlled trial and will be conducted in two phases. Phase one is a randomised feasibility and safety pilot trial involving 40 consecutive patients. After definitive sample size calculation, additional patients will be included accordingly during phase two. The primary outcome of the study will be the postoperative length of hospitalization until reaching previously defined \"fit for discharge criteria\". Secondary outcomes will include postoperative morbidity, mortality and postoperative AL-rates based on 90-day follow-up. A confirmatory analysis based on intention-to-treat will be performed.</p><p><strong>Ethics and dissemination: </strong>The ethics committee of the University of Zurich approved this study (2019-00562), which has been registered with <i>ClinicalTrials.gov</i> on 14.11.2019 (NCT04162860) and the Swiss National Clinical Trials Portal (SNCTP000003524). The results of the study will be published and presented at appropriate conferences.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":" ","pages":"7-15"},"PeriodicalIF":0.9,"publicationDate":"2021-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38918218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
International Journal of Surgery Protocols
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1